introgen therapeutics inc
(INGNQ:OTC US)

Executive Profile*

Background*

Mr. Jack A. Roth, M.D., serves as Chief Medical Advisor of M.D. Anderson Cancer Center. Dr. Roth serves as the Chairman and Member of the Scientific Advisory Board of Introgen Therapeutics, Inc. He serves as a Member of Clinical Advisory Board of Neotropix, Inc. He is Chairman of the Department of Thoracic and Cardiovascular Surgery and Director of the W.M. Keck Center for Cancer Gene Therapy at M.D. Anderson Cancer Center where he holds the Bud Johnson Clinical Distinguished ... Chair and was one of its founders. He is a widely-recognized pioneer in the application of targeted molecular therapies to the treatment of cancer. Dr. Roth is renowned expert in biology and treatment of lung cancer and has extensive experience in virotherapy based Phase I/II clinical trials for lung cancer. He is the primary inventor of the technology supporting its tumor suppressor products. Dr. Roth received his M.D. from The Johns Hopkins University School of Medicine and BA from Cornell UniversityJohns Hopkins University School of Medicine. He received Postgraduate Research Fellowship from UCLA Center for the Health Sciences and Residency in General Surgery and Thoracic Surgery from UCLA School of Medicine.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
INGNQ:US	$0.00 USD	0.00

COMPETITOR COMPENSATION